Literature DB >> 2273500

Microangiopathy in the eosinophilia-myalgia syndrome.

S A Smith1, R I Roelofs, E Gertner.   

Abstract

The eosinophilia-myalgia syndrome associated with the ingestion of L-tryptophan was recognized in late 1989. We describe our pathologic study of skin, fascial, and muscle biopsies from 21 patients evaluated by light microscopy, histochemistry, and electron microscopy. A perivascular, lymphocytic infiltrate with eosinophils was present in the dermis, fascia, and skeletal muscle. Lymphocytic infiltration of arteries and arterioles was seen. Ultrastructurally, capillary and arteriolar endothelial cell thickening and necrosis was present. This microangiopathy suggests that ischemia may be a contributing factor to the findings in this syndrome.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2273500

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  2 in total

1.  Antineutrophil cytoplasmic antibodies and the eosinophilia myalgia syndrome.

Authors:  A Schnabel; W L Gross; P A Berg; R Klein; H Lehnert
Journal:  Ann Rheum Dis       Date:  1995-03       Impact factor: 19.103

2.  Microscopic polyangiitis initiated with liver dysfunction, calf pain and fever of unknown origin.

Authors:  Kei Ohnuma; Osamu Hosono; Tomoki Katayose; Noritada Yoshikawa; Hiroshi Kawasaki; Takeshi Fujii; Naoki Oyaizu; Hirotoshi Tanaka; Chikao Morimoto
Journal:  Rheumatol Int       Date:  2009-09-23       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.